SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-14-000008
Filing Date
2014-05-23
Accepted
2014-05-23 16:03:17
Documents
1
Period of Report
2014-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnbt52314form8k.htm 8-K 29731
  Complete submission text file 0001607062-14-000008.txt   30831
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0314
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 14867237
SIC: 2834 Pharmaceutical Preparations